Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET

被引：0
|
作者：
Jussi Hirvonen
Hasse Karlsson
Jaana Kajander
Juha Markkula
Helena Rasi-Hakala
Kjell Någren
Jouko K. Salminen
Jarmo Hietala
机构：
[1] University of Turku,Department of Psychiatry
[2] University of Turku and Turku University Central Hospital,Turku PET Centre
[3] University of Helsinki,Department of Psychiatry
[4] The Social Insurance Institution of Finland,undefined
来源：
Psychopharmacology | 2008年 / 197卷
关键词：
Dopamine; Depression; Positron emission tomography; D; receptor; Imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：581 / 590
页数：9
相关论文
共 50 条
  • [41] In vivo quantification of striatal dopamine D2 receptor expression and [11C]raclopride affinity using a single injection protocol
    Fischer, Kristina
    Wimberley, Catriona
    Magg, Janine
    Huu Phuc Nguyen
    Gregoire, Marie-Claude
    Pichler, Bernd
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S68 - S69
  • [42] Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride
    Hirvonen, J
    Aalto, S
    Lumme, V
    Någren, K
    Kajander, J
    Vilkman, H
    Hagelberg, N
    Oikonen, V
    Hietala, J
    NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (12) : 1207 - 1214
  • [43] Striatal dopamine release during performance of executive functions:: A [11C] raclopride PET study
    Monchi, Oury
    Ko, Ji Hyun
    Strafella, Antonio P.
    NEUROIMAGE, 2006, 33 (03) : 907 - 912
  • [44] Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain
    Volkow, Nora D.
    Wang, Gene-Jack
    Telang, Frank
    Fowler, Joanna S.
    Logan, Jean
    Wong, Christopher
    Ma, Jim
    Pradhan, Kith
    Tomasi, Dardo
    Thanos, Peter K.
    Ferre, Sergi
    Jayne, Millard
    JOURNAL OF NEUROSCIENCE, 2008, 28 (34): : 8454 - 8461
  • [45] Effects of fluoxetine on dopamine D2 receptors in the human brain:: a positron emission tomography study with [11C]raclopride
    Penttilä, J
    Kajander, J
    Aalto, S
    Hirvonen, J
    Någren, K
    Ilonen, T
    Syvälahti, E
    Hietala, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (04): : 431 - 439
  • [46] Sequential Versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride:: Effect of methamphetamine
    Doudet, DJ
    Holden, TE
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (12): : 1489 - 1494
  • [47] Dopamine D2/3 Receptor Occupancy of Apomorphine in the Nonhuman Primate Brain-A Comparative PET Study With [11C]Raclopride and [11C]MNPA
    Finnema, Sjoerd J.
    Halldin, Christer
    Bang-Andersen, Benny
    Gulyas, Balazs
    Bundgaard, Christoffer
    Wikstrom, Hakan V.
    Farde, Lars
    SYNAPSE, 2009, 63 (05) : 378 - 389
  • [48] Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride
    Kodaka, Fumitoshi
    Ito, Hiroshi
    Kimura, Yasuyuki
    Fujie, Saori
    Takano, Harumasa
    Fujiwara, Hironobu
    Sasaki, Takeshi
    Nakayama, Kazuhiko
    Halldin, Christer
    Farde, Lars
    Suhara, Tetsuya
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 574 - 579
  • [49] Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride
    Fumitoshi Kodaka
    Hiroshi Ito
    Yasuyuki Kimura
    Saori Fujie
    Harumasa Takano
    Hironobu Fujiwara
    Takeshi Sasaki
    Kazuhiko Nakayama
    Christer Halldin
    Lars Farde
    Tetsuya Suhara
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 574 - 579
  • [50] In vivo vulnerability to endogenous dopamine:: Comparison of the dopamine-2 (D2) agonist tracer [11C]-n-propylnorapomorphine ([11C]NPA) with the D2 antagonist tracer [11C]raclopride.
    Narendran, R
    Talbot, PS
    Kegeles, LS
    Martinez, D
    Huang, Y
    Ngo, K
    Hackett, E
    Castrillon, J
    Abi-Dargham, A
    Laruelle, M
    Hwang, DR
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 71P - 71P
12345